logo
Plus   Neg
Share
Email

Ligand Pharmaceuticals Inc Q3 adjusted earnings Miss Estimates

Below are the earnings highlights for Ligand Pharmaceuticals Inc (LGND):

-Earnings: -$15.25 million in Q3 vs. $67.36 million in the same period last year.
-EPS: -$0.81 in Q3 vs. $2.80 in the same period last year.
-Excluding items, Ligand Pharmaceuticals Inc reported adjusted earnings of $9.54 million or $0.49 per share for the period.
-Analysts projected $0.61 per share
-Revenue: $24.81 million in Q3 vs. $45.66 million in the same period last year.

-Guidance:
Full year EPS guidance: $3.00

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>